Pure Global

Effects of AHCL Insulin Pump on Glycemic Control and Psychosocial Outcomes in Pediatric Patients With Type 1 Diabetes - Trial NCT06414564

Access comprehensive clinical trial information for NCT06414564 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul National University Hospital and is currently Recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06414564
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06414564
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Effects of AHCL Insulin Pump on Glycemic Control and Psychosocial Outcomes in Pediatric Patients With Type 1 Diabetes
Effects of Advanced Hybrid Closed-loop System on Glycemic Control and Psychosocial Outcomes in Pediatric Patients With Type 1 Diabetes

Study Focus

Type 1 Diabetes

Medtronic 780G insulin pump

Interventional

device

Sponsor & Location

Seoul National University Hospital

Seoul, South Korea

Timeline & Enrollment

N/A

Feb 01, 2024

Dec 31, 2025

30 participants

Primary Outcome

Time In Range (TIR)

Summary

Prospective, non-randomized, single-arm clinical trial to investigate the effects of advanced
 hybrid close-loop (AHCL) system insulin pump in pediatric patients with type 1 diabetes

ICD-10 Classifications

Type 1 diabetes mellitus
Type 1 diabetes mellitus without complications
Type 1 diabetes mellitus with unspecified complications
Type 1 diabetes mellitus with other specified complications
Type 1 diabetes mellitus with multiple complications

Data Source

ClinicalTrials.gov

NCT06414564

Device Trial